BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7302505)

  • 1. The treatment of arterial hypertension with acebutolol. Its effect on the urinary catecholamine excretion.
    Streian C; Comşulea L; Deutsch G; Mangiuca M; Ienea A
    Med Interne; 1981; 19(3):259-63. PubMed ID: 7302505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hypotensive treatment on the excretion of catecholamines and their metabolites in patients with essential hypertension].
    Brym E
    Kardiol Pol; 1979; 22(2):129-37. PubMed ID: 439575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Essential arterial hypertension with elevated urinary excretion of free catecholamines. Chronobiological study].
    Trotta A; Acitelli P; Cicogna S; Di Pietro M; Spacca G; Natali G
    G Ital Cardiol; 1982; 12(11):780-4. PubMed ID: 7182217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
    Lil'in ET; Vavilova TA; Mar'in MI
    Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
    [No Abstract]   [Full Text] [Related]  

  • 5. [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
    Pieniazek W; Franczuk P; Janicki K
    Przegl Lek; 2001; 58(5):411-4. PubMed ID: 11603173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihypertensive effect and inhibition of the sympathetic nervous system by acebutolol].
    Hardin JM; Fournier A; Alexandre JM; Lombaert M; Ronco G; Bezoc JF; Desmet ; Quichaud J
    J Urol Nephrol (Paris); 1976 Sep; 82(9):792-8. PubMed ID: 994296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of the strength of the central nervous system in the variability of reactions to acebutolol].
    Zamotaev IP; Lil'in ET; Abramova VG; Vavilova TA
    Sov Med; 1983; (3):24-8. PubMed ID: 6857369
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the hypotensive effect of acebutolol (Sectral)].
    Brym E; Cybulska I; Czerniewska E
    Pol Tyg Lek; 1982 Nov; 37(44):1323-6. PubMed ID: 6761673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of light and moderate arterial hypertension with acebutolol].
    Kaloianova A; Nikolov G; Tsolov S; Sotirov I; Tsanov N
    Vutr Boles; 1986; 25(4):54-60. PubMed ID: 3765591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of Effortil therapy on the urinary catecholamine excretion].
    Baltă N; Bubuianu G; Cruceanu I; Căpilnă S; Drăgulescu N
    Fiziol Norm Patol; 1973; 19(4):331-7. PubMed ID: 4741265
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
    Villalpando J; Skromme D; Chávez B; Serrano P
    Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acebutolol in the therapy of mild and moderate hypertension].
    Widimský J
    Vnitr Lek; 1994 Jan; 40(1):14-6. PubMed ID: 8140743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New therapeutic approach to arterial hypertension using acebutolol].
    Accardo G
    G Clin Med; 1982 May; 63(5):330-6. PubMed ID: 7141175
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of acebutolol in arterial hypertension. Apropos of 13 records of Senegalese patients].
    Koate P; Diouf S; Sylla M; Sarr M
    Dakar Med; 1982; 27(4):547-64. PubMed ID: 7184740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents].
    Sirotiaková J; Mlyncek M; Kriska M; Letkovicová M
    Ceska Gynekol; 2002 Jan; 67(1):8-15. PubMed ID: 11881282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acebutolol as monotherapy of essential arterial hypertension].
    Mazzaferro S; Giuliano G; Lucchini M; Airoldi G; Finistauri D; Massimetti C; Messa F; Coen G
    Clin Ter; 1984 May; 109(4):315-21. PubMed ID: 6236025
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects.
    Krouf D; Bouchenak M; Mohammedi B; Cherrad A; Belleville JL; Prost JL
    Med Sci Monit; 2003 Aug; 9(8):PI109-15. PubMed ID: 12942043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acebutolol: experience with its use in ambulatory management of arterial hypertension].
    Battaglia A; Adamo M
    Minerva Med; 1983 Mar; 74(9-10):493-8. PubMed ID: 6340002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of acebutolol in arterial hypertension. Apropos of 31 case records of Senegalese patients].
    Koaté P; Diouf S; Sylla M; Diop G; Sarr M; Ba SA
    Dakar Med; 1983; 28(2):299-319. PubMed ID: 6653328
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hypertension with acebutolol.
    Fah NT
    Med J Malaysia; 1977 Dec; 32(2):127-32. PubMed ID: 614478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.